The European healthcare technology sector has entered a protracted period of structural realignment, precipitated by the breakdown of the historical venture capital funding escalator. Between 2020 and 2021, zero-interest-rate monetary policies and temporary pandemic tailwinds channeled speculative capital into early-stage digital health platforms, creating inflated entry valuations and subsidising unsustainable operational burn rates.

Private capital allocation across the global healthcare and life sciences landscape reached an unprecedented structural inflection point during the first half of 2026. Driven by ongoing institutional portfolio rebalancing, prolonged liquidity constraints and shifting reimbursement fundamentals, the market has bifurcated into a high concentration fundraising environment alongside an acute divergence in sub-sector investment performance.

The global healthcare investment landscape is experiencing a structural rotation toward non-discretionary, enterprise-funded healthcare services. Occupational healthcare has emerged as a primary focus of institutional capital deployment, shifting from a transactional human resources support function into a strategic, board-level priority for risk management and workforce preservation. Private equity sponsors are deploying capital across this sub sector to capitalise on insul

Fewer, larger, more selective: what the first half of 2026 tells us about where private capital is going in MedTech, and how investors should think about carve-outs, take-privates and the categories that are attracting the biggest cheques. The headline number for MedTech M&A in 2026 is striking. In the first half of the year, deal value was roughly 160% higher than the same period in 2025. The more interesting number sits beside it: deal count rose by just 5%. Average deal v

The United Kingdom occupational health (OH) market is undergoing an unprecedented structural consolidation driven by private equity capital deployment, corporate carve outs, and buy and build strategies. Valued between £1.5 billion and £2.0 billion and expanding at an annual growth rate of 6% to 9%, the sector sits at the intersection of acute macroeconomic pressures, severe healthcare labour constraints and evolving statutory obligations for employers. Over the past 24 month